Tuesday, 13 May 2025
  
Login

Australia's most trusted
source of pharma news

Tuesday, 13 May 2025
Ascott/Vivacity
Ascott/Vivacity
Govt quietly funds Novartis therapy

The latest twist for this major new Novartis treatment has seen the Federal Government quietly agree to funding for the first-of-a-kind therapy in Australia.

Butler returns in supersized role
With new portfolios added to his remit Medicines Australia is urging that fixing the HTA system must be the Minister's priority
TODAY
Leaders named for Sanofi spin-off
Opella ANZ has hit the ground running, announcing its new GM, its leadership team and new Sydney office space
TODAY
Medscape
Medscape
High-flyer says goodbye... for now
As one executive takes a break before the next career move, others are landing new roles or climbing the ladder
12 May
PBAC Agenda blows out to 59
Two new drugs are among 11 additions to the PBAC's July agenda, stretching the total number of items under consideration to almost 60
12 May
Lilly beats rival in epic showdown
Winner emerges in a head-to-head study comparing two drugs in the most lucrative and hotly contested market in pharma
12 May
Splashing millions on meetings
Find out which pharmas spent millions in just six months on third party meeting sponsorships across ANZ
9 May
ARCS
ARCS
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (12)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (4)

Executive Roles (1)

Other (14)

Blockbuster taps new indication
TGA follows MedSafe and approves a new indication which has already been given the nod for reimbursement
12 May
Tuberculosis drug finally approved
First generic of GSK drug plus new use for chemotherapy also registered on the ARTG
12 May Approvals Action
Albo joins pharma CEOs on top list
TIME Magazine names PM alongside half a dozen pharma bigwigs on its global list of most influential in health, find out why
9 May
Is paid childcare the new hot perk?
ICYMI: A deep dive into the benefits pharma staff treasure reveals what's most sought-after... and what's on the radar
9 May Your Week in Five Minutes
Drug flood overwhelming HCPs
Cancer doctors struggle with the speed at which new treatments are launched and guidelines are updated
9 May
PBS drug touts complete response
New data suggests the PD-1 inhibitor can trigger complete tumour clearance, particularly in one certain type of cancer
9 May
CEOs earn 200X more than staff
New analysis uncovers the boss-worker pay gap and also lifts the lid on the median salary across companies
8 May
Trump floats bad policy for Aust
After months of talking softly, reports of a policy move by Trump could see the industry look to wield a big lobbying stick
8 May
What downturn? Pharma is back
Despite talk of headwinds, 2024 was a good year for the pharma industry with revenues booming for just about everyone
8 May
Company grows leadership team
Three major internal promotions, a series of leadership changes plus a handful of jobs now up for grabs at this growing pharma
8 May
Amgen shields $324 million drug
Company demands documents relating to biosim's ARTG listing to launch potential patent infringement case
8 May
Access gap blows out to 676 days
New figures show the time patients must wait for access to medicines has ballooned to a disturbing 22 months
7 May
Migraine drug scores double win
First-ever study to demonstrate significant improvements in migraine and depressive symptoms with a single drug
7 May
How leaders can fix disengagement
Aussie executive coach describes disengagement as frightening and urges companies to equip people leaders with the right tools
7 May
ADG aus Doc
ADG Aus Doc
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.